JP2001501823A5 - - Google Patents

Download PDF

Info

Publication number
JP2001501823A5
JP2001501823A5 JP1998516912A JP51691298A JP2001501823A5 JP 2001501823 A5 JP2001501823 A5 JP 2001501823A5 JP 1998516912 A JP1998516912 A JP 1998516912A JP 51691298 A JP51691298 A JP 51691298A JP 2001501823 A5 JP2001501823 A5 JP 2001501823A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998516912A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001501823A (ja
Filing date
Publication date
Priority claimed from US08/725,532 external-priority patent/US6020179A/en
Application filed filed Critical
Publication of JP2001501823A publication Critical patent/JP2001501823A/ja
Publication of JP2001501823A5 publication Critical patent/JP2001501823A5/ja
Ceased legal-status Critical Current

Links

JP10516912A 1996-10-03 1997-10-02 疾病関連プロテインチロシンホスファターゼ Ceased JP2001501823A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/725,532 US6020179A (en) 1996-10-03 1996-10-03 Nucleic acids encoding human tyrosine phosphatases
US08/725,532 1996-10-03
PCT/US1997/017890 WO1998014596A2 (en) 1996-10-03 1997-10-02 Disease associated protein tyrosine phosphatases

Publications (2)

Publication Number Publication Date
JP2001501823A JP2001501823A (ja) 2001-02-13
JP2001501823A5 true JP2001501823A5 (enExample) 2005-06-16

Family

ID=24914927

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10516912A Ceased JP2001501823A (ja) 1996-10-03 1997-10-02 疾病関連プロテインチロシンホスファターゼ

Country Status (6)

Country Link
US (1) US6020179A (enExample)
EP (1) EP0951556A2 (enExample)
JP (1) JP2001501823A (enExample)
AU (1) AU4667397A (enExample)
CA (1) CA2265449A1 (enExample)
WO (1) WO1998014596A2 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156551A (en) * 1998-06-05 2000-12-05 Beth Israel Deaconess Medical Center Activated mutants of SH2-domain-containing protein tyrosine phosphatases and methods of use thereof
US6258582B1 (en) * 1998-09-30 2001-07-10 Millennium Pharmaceuticals, Inc. CSAPTP nucleic acid molecules and uses therefor
AU6410599A (en) * 1998-09-30 2000-04-17 Millennium Pharmaceuticals, Inc. Novel protein phosphatase molecules and uses therefor
DE10015818A1 (de) * 2000-03-30 2001-10-18 Infineon Technologies Ag Biosensor und Verfahren zum Ermitteln makromolekularer Biopolymere mit einem Biosensor
US6465632B1 (en) * 2000-06-09 2002-10-15 Lexicon Genetics Incorporated Human phosphatases and polynucleotides encoding the same
CN1331327A (zh) * 2000-06-26 2002-01-16 上海博德基因开发有限公司 一种新的多肽——人纹状体富集磷酸酶14.85和编码这种多肽的多核苷酸
US20030118585A1 (en) * 2001-10-17 2003-06-26 Agy Therapeutics Use of protein biomolecular targets in the treatment and visualization of brain tumors
US7744867B2 (en) * 2001-05-31 2010-06-29 The Cleveland Clinic Foundation PTPase inhibitors and method of using same
US20040010045A1 (en) * 2001-09-07 2004-01-15 Taolin Yi Therapeutic compositions comprised of pentamidine and methods of using same to treat cancer
WO2003070158A2 (en) * 2001-09-07 2003-08-28 The Cleveland Clinic Foundation Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases
US20050215629A1 (en) * 2001-09-07 2005-09-29 Taolin Yi PTPase inhibitors and methods of using the same
US20030161893A1 (en) * 2001-09-07 2003-08-28 Taolin Yi PTPase inhibitors and methods of using the same
WO2003031930A2 (en) * 2001-10-09 2003-04-17 The Johns Hopkins University A phosphatase associated with metastasis
WO2003092616A2 (en) * 2002-05-01 2003-11-13 The Cleveland Clinic Foundation Therapeutic compositions comprised of pentamidine and methods of using same to treat cancer
US20100009929A1 (en) 2004-03-29 2010-01-14 Cheng Jin Q Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof
US20100009928A1 (en) 2004-03-29 2010-01-14 Cheng Jin Q Compositions including triciribine and taxanes and methods of use thereof
US20100028339A1 (en) 2004-03-29 2010-02-04 Cheng Jin Q Compositions including triciribine and trastuzumab and methods of use thereof
US8435959B2 (en) 2004-03-29 2013-05-07 University Of South Florida Effective treatment of tumors and cancer with triciribine and related compounds
US20100173864A1 (en) 2004-03-29 2010-07-08 Cheng Jin Q Compositions including triciribine and one or more platinum compounds and methods of use thereof
US20110008327A1 (en) * 2004-03-29 2011-01-13 Cheng Jin Q Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof
CN1870631B (zh) * 2005-11-11 2010-04-14 华为技术有限公司 媒体网关的门控方法
WO2007082052A2 (en) * 2006-01-11 2007-07-19 The Cleveland Clinic Foundation Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases
WO2007149381A2 (en) * 2006-06-19 2007-12-27 The Cleveland Clinic Foundation Compositions comprising a ptp-ase inhibitor and use thereof in treating cancer
US20080226596A1 (en) * 2006-06-19 2008-09-18 Taolin Yi Therapeutic compositions and methods useful in treating hepatitis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6688696A (en) * 1995-08-10 1997-03-05 Incyte Pharmaceuticals, Inc. Non-receptor type human protein tyrosine phosphatase

Similar Documents

Publication Publication Date Title
JP2000502280A5 (enExample)
JP2000501771A5 (enExample)
JP2000501599A5 (enExample)
JP2000501018A5 (enExample)
JP2000500076A5 (enExample)
JP2000501324A5 (enExample)
JP2000500055A5 (enExample)
JP2000500026A5 (enExample)
JP2000502472A5 (enExample)
JP2000501825A5 (enExample)
JP2000501338A5 (enExample)
JP2000500874A5 (enExample)
JP2000502485A5 (enExample)
JP2000502425A5 (enExample)
JP2000502568A5 (enExample)
JP2000501774A5 (enExample)
JP2000500912A5 (enExample)
JP2000502570A5 (enExample)
JP2000501876A5 (enExample)
JP2000501744A5 (enExample)
JP2000501229A5 (enExample)
JP2000502316A5 (enExample)
JP2000500857A5 (enExample)
JP2000502714A5 (enExample)
JP2000501569A5 (enExample)